Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
RNAZ
$11.93
-5.99%
Analyze
1M
+17.3%
3M
+1.6%
1Y
-38.5%
Market Cap:
$9.95M
Transcode Therapeutics Inc
Healthcare |
Biotechnology
TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic diseases. The company is headquartered in Boston, Massachusetts.
Click "Analyze" to generate stock analysis
RNAZ Price Trend and Signals
RNAZ Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-22
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-17
Somewhat Bullish
price_signal
Half-yearly high detected.
2025-10-16
Somewhat Bullish
price_signal
Half-yearly high detected.
2025-10-15
Somewhat Bullish
price_signal
Half-yearly high detected.